Outcomes of COVID-19 Hospitalized Patients Previously Treated with Renin-Angiotensin System Inhibitors

(1) Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) penetrates respiratory epithelium through angiotensin-converting enzyme-2 binding, raising concerns about the potentially harmful effects of renin–angiotensin system inhibitors (RASi) on Human Coronavirus Disease 2019 (COVI...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Med
Main Authors: Cordeanu, Elena-Mihaela, Jambert, Lucas, Severac, Francois, Lambach, Hélène, Tousch, Jonathan, Heitz, Marie, Mirea, Corina, Hamadé, Amer, Younes, Waël, Frantz, Anne-Sophie, Merdji, Hamid, Schini-Kerth, Valérie, Bilbault, Pascal, Meziani, Ferhat, Ohlmann, Patrick, Andres, Emmanuel, Stephan, Dominique
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7692895/
https://ncbi.nlm.nih.gov/pubmed/33126565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9113472
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki